Trust Chem Co., Ltd. (SHE:001335)
China
· Delayed Price · Currency is CNY 47.87
+0.10 (0.21%)
Apr 30, 2026, 12:54 PM CST
Trust Chem Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Operating Revenue | 1,313 | 1,394 | 1,062 | 1,192 | 1,206 |
| Other Revenue | - | 23.02 | 7.11 | - | - |
| Revenue | 1,313 | 1,417 | 1,069 | 1,192 | 1,206 |
| Revenue Growth (YoY) | -7.33% | 32.55% | -10.37% | -1.10% | - |
| Cost of Revenue | 1,115 | 1,216 | 898.71 | 1,011 | 1,014 |
| Gross Profit | 197.96 | 200.48 | 170.01 | 180.93 | 191.84 |
| Selling, General & Admin | 111.35 | 90.95 | 82.42 | 73.48 | 66.91 |
| Research & Development | 14.77 | 6.15 | 5.53 | 4.44 | 4.11 |
| Other Operating Expenses | -0.02 | 2.1 | -2.39 | 2.13 | 2.31 |
| Operating Expenses | 126.1 | 100.07 | 86.53 | 77.5 | 76.03 |
| Operating Income | 71.86 | 100.41 | 83.48 | 103.43 | 115.81 |
| Interest Expense | - | -6.35 | -4.59 | -5.39 | -2.4 |
| Interest & Investment Income | 22.16 | 23.97 | 24.05 | 8.35 | 2.89 |
| Currency Exchange Gain (Loss) | - | 7.13 | 8.32 | 13.73 | -10.94 |
| Other Non Operating Income (Expenses) | 10.85 | -1.9 | 0.94 | -2.35 | -0.71 |
| EBT Excluding Unusual Items | 104.87 | 123.26 | 112.2 | 117.77 | 104.66 |
| Gain (Loss) on Sale of Investments | -11.18 | 6.64 | -7.8 | -14.4 | 9.12 |
| Gain (Loss) on Sale of Assets | 0.06 | -0 | -0.01 | 0.08 | - |
| Asset Writedown | -13.97 | - | - | - | -0.2 |
| Other Unusual Items | - | 1.85 | 0.01 | 9.95 | 4.46 |
| Pretax Income | 79.78 | 131.75 | 104.39 | 113.39 | 118.04 |
| Income Tax Expense | 11.38 | 26.65 | 19.84 | 28.08 | 28.98 |
| Earnings From Continuing Operations | 68.4 | 105.11 | 84.55 | 85.31 | 89.06 |
| Minority Interest in Earnings | 9.42 | 6.12 | 3.51 | 2.34 | -0.04 |
| Net Income | 77.82 | 111.23 | 88.06 | 87.65 | 89.02 |
| Net Income to Common | 77.82 | 111.23 | 88.06 | 87.65 | 89.02 |
| Net Income Growth | -30.04% | 26.31% | 0.47% | -1.54% | - |
| Shares Outstanding (Basic) | 86 | 70 | 70 | 70 | 60 |
| Shares Outstanding (Diluted) | 86 | 70 | 70 | 70 | 60 |
| Shares Change (YoY) | 21.64% | -0.21% | 0.47% | 16.57% | - |
| EPS (Basic) | 0.91 | 1.58 | 1.25 | 1.25 | 1.48 |
| EPS (Diluted) | 0.91 | 1.58 | 1.25 | 1.25 | 1.48 |
| EPS Growth | -42.41% | 26.40% | - | -15.54% | - |
| Free Cash Flow | -102.59 | -71.13 | -7.98 | -38.71 | -80.66 |
| Free Cash Flow Per Share | -1.20 | -1.01 | -0.11 | -0.55 | -1.34 |
| Dividend Per Share | - | 0.150 | - | - | - |
| Gross Margin | 15.08% | 14.15% | 15.91% | 15.17% | 15.91% |
| Operating Margin | 5.47% | 7.09% | 7.81% | 8.67% | 9.61% |
| Profit Margin | 5.93% | 7.85% | 8.24% | 7.35% | 7.38% |
| Free Cash Flow Margin | -7.81% | -5.02% | -0.75% | -3.25% | -6.69% |
| EBITDA | 106.73 | 125.44 | 93.25 | 106.92 | 119.26 |
| EBITDA Margin | 8.13% | 8.86% | 8.72% | 8.97% | 9.89% |
| D&A For EBITDA | 34.87 | 25.03 | 9.76 | 3.5 | 3.45 |
| EBIT | 71.86 | 100.41 | 83.48 | 103.43 | 115.81 |
| EBIT Margin | 5.47% | 7.09% | 7.81% | 8.67% | 9.61% |
| Effective Tax Rate | 14.26% | 20.23% | 19.01% | 24.76% | 24.55% |
| Advertising Expenses | - | 1.5 | 1.8 | 1.1 | 0.34 |
Source: S&P Capital IQ. Standard template. Financial Sources.